Brasília – A new national study presented at a hematology congress identifies the demanding routine of frequent intravenous infusions as the main barrier to treatment adherence among people living with hemophilia in Brazil. According to the findings, patients who require more than two infusions per week report significant difficulty maintaining consistency, pointing to treatment burden as a central challenge.

Specialists from 13 states highlight that the high frequency of administration affects quality of life, mobility and autonomy, with consequences for long-term outcomes. The study reinforces the need for therapeutic approaches that reduce treatment burden and improve adherence, particularly within the public health system.

Source: Correio Braziliense